# Intra Articular Injection of Peripheral Blood Mononuclear Cells for Knee Osteoarthritis

> **NCT07703280** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **DuoGenic StemCells Corporation (DGSC)** · enrollment: 240 (estimated)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **BIOLOGICAL:** High-dose PCP-PBMCs injection
- **DRUG:** Solu-Medrol
- **BIOLOGICAL:** Low-dose PCP-PBMCs injection

## Key facts

- **NCT ID:** NCT07703280
- **Lead sponsor:** DuoGenic StemCells Corporation (DGSC)
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-30
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-07-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07703280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07703280, "Intra Articular Injection of Peripheral Blood Mononuclear Cells for Knee Osteoarthritis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07703280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*